Trevena, Inc. stock price

Trevena, Inc. latest news:


  • 01/05/2018 14:17:05

    BRIEF-Trevena Inc Says FDA Indicated To Co That PDUFA Date For Olinvo NDA Is Nov 2‍​

    * TREVENA INC - ON JAN 5, FDA INDICATED TO THE CO THAT PDUFA REVIEW DATE FOR OLINVO NDA IS NOV 2‍​

  • 01/02/2018 14:19:54

    Trevena shares rally as FDA accepts painkiller marketing application for review

    Trevena Inc. shares jumped in the extended session Tuesday after the biotech company said the Food and Drug Administration accepted for review a marketing application for its opioid-replacement painkiller. Shares, which had jumped as much as 25%, traded up 18% at $2.12 after hours. The company said the FDA is expected to make a decision on the application for the drug Olinvo in the fourth quarter of 2018. Olinvo was shown to deliver the pain relief of a conventional opioid like morphine with fewer adverse effects, the company said.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    TriCo BancsharesTCBK | Trillium Therapeutics Inc.TRIL | TriMas CorporationTRS | Trimble Navigation LimitedTRMB | Trinity Biotech plcTRIB | TripAdvisor, Inc.TRIP | TriState Capital Holdings, Inc.TSC | Triumph Bancorp, Inc.TBK | TriVascular Technologies, Inc.TRIV | TrovaGene, Inc.TROV |